These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 26897559)
1. Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma. Mead B; Hill LJ; Blanch RJ; Ward K; Logan A; Berry M; Leadbeater W; Scheven BA Cytotherapy; 2016 Apr; 18(4):487-96. PubMed ID: 26897559 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma. Mead B; Amaral J; Tomarev S Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):702-714. PubMed ID: 29392316 [TBL] [Abstract][Full Text] [Related]
3. The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss. Blanco R; Martínez-Navarrete G; Valiente-Soriano FJ; Avilés-Trigueros M; Pérez-Rico C; Serrano-Puebla A; Boya P; Fernández E; Vidal-Sanz M; de la Villa P Exp Eye Res; 2017 Nov; 164():37-45. PubMed ID: 28827028 [TBL] [Abstract][Full Text] [Related]
4. Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms. Mead B; Tomarev S Stem Cells Transl Med; 2017 Apr; 6(4):1273-1285. PubMed ID: 28198592 [TBL] [Abstract][Full Text] [Related]
5. Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury. Mead B; Logan A; Berry M; Leadbeater W; Scheven BA Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7544-56. PubMed ID: 24150755 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of intravitreally transplanted adipose tissue and bone marrow-derived mesenchymal stem cells in an experimental ocular hypertension model. Emre E; Yüksel N; Duruksu G; Pirhan D; Subaşi C; Erman G; Karaöz E Cytotherapy; 2015 May; 17(5):543-59. PubMed ID: 25618560 [TBL] [Abstract][Full Text] [Related]
7. Relating Retinal Ganglion Cell Function and Retinal Nerve Fiber Layer (RNFL) Retardance to Progressive Loss of RNFL Thickness and Optic Nerve Axons in Experimental Glaucoma. Fortune B; Cull G; Reynaud J; Wang L; Burgoyne CF Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3936-44. PubMed ID: 26087359 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Johnson TV; Bull ND; Hunt DP; Marina N; Tomarev SI; Martin KR Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2051-9. PubMed ID: 19933193 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of the endothelin A (ET McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in a Genetic DBA/2J Mouse Model of Glaucoma. Mead B; Ahmed Z; Tomarev S Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5473-5480. PubMed ID: 30452601 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of retinal ganglion cell damage in three glaucomatous rat models. Huang W; Hu F; Wang M; Gao F; Xu P; Xing C; Sun X; Zhang S; Wu J Exp Eye Res; 2018 Jul; 172():112-122. PubMed ID: 29605491 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotection of Transplanting Human Umbilical Cord Mesenchymal Stem Cells in a Microbead Induced Ocular Hypertension Rat Model. Ji S; Lin S; Chen J; Huang X; Wei CC; Li Z; Tang S Curr Eye Res; 2018 Jun; 43(6):810-820. PubMed ID: 29505314 [TBL] [Abstract][Full Text] [Related]
15. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat. Lau J; Dang M; Hockmann K; Ball AK Exp Eye Res; 2006 Jan; 82(1):132-45. PubMed ID: 16045909 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic Transplantation of Müller-Derived Retinal Ganglion Cells Improves Retinal Function in a Feline Model of Ganglion Cell Depletion. Becker S; Eastlake K; Jayaram H; Jones MF; Brown RA; McLellan GJ; Charteris DG; Khaw PT; Limb GA Stem Cells Transl Med; 2016 Feb; 5(2):192-205. PubMed ID: 26718648 [TBL] [Abstract][Full Text] [Related]
17. Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model. Danias J; Shen F; Kavalarakis M; Chen B; Goldblum D; Lee K; Zamora MF; Su Y; Brodie SE; Podos SM; Mittag T Exp Eye Res; 2006 Feb; 82(2):219-28. PubMed ID: 16109406 [TBL] [Abstract][Full Text] [Related]
18. Hybrid Compound SA-2 is Neuroprotective in Animal Models of Retinal Ganglion Cell Death. Stankowska DL; Dibas A; Li L; Zhang W; Krishnamoorthy VR; Chavala SH; Nguyen TP; Yorio T; Ellis DZ; Acharya S Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3064-3073. PubMed ID: 31348824 [TBL] [Abstract][Full Text] [Related]
19. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions. Huang Y; Cen LP; Choy KW; van Rooijen N; Wang N; Pang CP; Cui Q Exp Eye Res; 2007 Nov; 85(5):684-95. PubMed ID: 17869246 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling. Osborne A; Khatib TZ; Songra L; Barber AC; Hall K; Kong GYX; Widdowson PS; Martin KR Cell Death Dis; 2018 Sep; 9(10):1007. PubMed ID: 30258047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]